Dr Anne-Louise Latif

  • Honorary Clinical Senior Lecturer (School of Medicine, Dentistry & Nursing)
  • Affiliate (School of Cancer Sciences)

email: Anne-Louise.Latif@glasgow.ac.uk

BMT and Cellular Therapy Unit, Queen Elizabeth University Hospital, Glasgow, G51 4TF

Import to contacts

Publications

List by: Type | Date

Jump to: 2021 | 2020 | 2016 | 2015 | 2013
Number of items: 6.

2021

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Laird, Jennifer, Latif, Anne-Louise, Irvine, David, Wilson, Matthew ORCID logoORCID: https://orcid.org/0000-0001-5423-3270 and Douglas, Kenneth (2021) The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

Latif, A.-L. et al. (2021) BRD4-mediated repression of p53 is a target for combination therapy in AML. Nature Communications, 12, 241. (doi: 10.1038/s41467-020-20378-8) (PMID:33431824) (PMCID:PMC7801601)

2020

Horne, G. et al. (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia, 34(7), pp. 1775-1786. (doi: 10.1038/s41375-019-0700-9) (PMID:31925317) (PMCID:PMC7224085)

2016

Latif, Anne-Louise and Holyoake, Tessa (2016) Lifting the differentiation embargo. Cell, 167(1), pp. 45-46. (doi: 10.1016/j.cell.2016.08.051) (PMID:27662083)

2015

Latif, Anne-Louise, Cole, John J., Monteiro Campos, Joana, Clark, Willliam, McGarry, Lynn, Brock, Claire, Newcombe, Ashley, Keeshan, Karen ORCID logoORCID: https://orcid.org/0000-0001-7266-0890, Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X and Adams, Peter D. (2015) Dual inhibition of MDM2 and BET cooperate to eradicate acute myeloid leukemia. Blood, 126(23), p. 674. (doi: 10.1182/blood.V126.23.674.674)

2013

Sinclair, A., Latif, A.L. and Holyoake, T.L. (2013) Targeting survival pathways in chronic myeloid leukaemia stem cells. British Journal of Pharmacology, 169(8), pp. 1693-1707. (doi: 10.1111/bph.12183)

This list was generated on Sun Jul 6 03:05:30 2025 BST.
Jump to: Articles
Number of items: 6.

Articles

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Laird, Jennifer, Latif, Anne-Louise, Irvine, David, Wilson, Matthew ORCID logoORCID: https://orcid.org/0000-0001-5423-3270 and Douglas, Kenneth (2021) The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

Latif, A.-L. et al. (2021) BRD4-mediated repression of p53 is a target for combination therapy in AML. Nature Communications, 12, 241. (doi: 10.1038/s41467-020-20378-8) (PMID:33431824) (PMCID:PMC7801601)

Horne, G. et al. (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia, 34(7), pp. 1775-1786. (doi: 10.1038/s41375-019-0700-9) (PMID:31925317) (PMCID:PMC7224085)

Latif, Anne-Louise and Holyoake, Tessa (2016) Lifting the differentiation embargo. Cell, 167(1), pp. 45-46. (doi: 10.1016/j.cell.2016.08.051) (PMID:27662083)

Latif, Anne-Louise, Cole, John J., Monteiro Campos, Joana, Clark, Willliam, McGarry, Lynn, Brock, Claire, Newcombe, Ashley, Keeshan, Karen ORCID logoORCID: https://orcid.org/0000-0001-7266-0890, Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X and Adams, Peter D. (2015) Dual inhibition of MDM2 and BET cooperate to eradicate acute myeloid leukemia. Blood, 126(23), p. 674. (doi: 10.1182/blood.V126.23.674.674)

Sinclair, A., Latif, A.L. and Holyoake, T.L. (2013) Targeting survival pathways in chronic myeloid leukaemia stem cells. British Journal of Pharmacology, 169(8), pp. 1693-1707. (doi: 10.1111/bph.12183)

This list was generated on Sun Jul 6 03:05:30 2025 BST.